- Home
- FTDR vs ICUI Comparison
FTDR vs ICUI Comparison
Compare FTDR & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTDR
- ICUI
- Stock Information
- Founded
- FTDR 1971
- ICUI 1984
- Country
- FTDR United States
- ICUI United States
- Employees
- FTDR N/A
- ICUI N/A
- Industry
- FTDR Diversified Commercial Services
- ICUI Medical/Dental Instruments
- Sector
- FTDR Finance
- ICUI Health Care
- Exchange
- FTDR Nasdaq
- ICUI Nasdaq
- Market Cap
- FTDR 3.6B
- ICUI 3.8B
- IPO Year
- FTDR 2018
- ICUI 1992
- Fundamental
- Price
- FTDR $58.53
- ICUI $163.87
- Analyst Decision
- FTDR Hold
- ICUI Buy
- Analyst Count
- FTDR 6
- ICUI 4
- Target Price
- FTDR $46.80
- ICUI $199.67
- AVG Volume (30 Days)
- FTDR 658.0K
- ICUI 212.8K
- Earning Date
- FTDR 02-26-2025
- ICUI 02-25-2025
- Dividend Yield
- FTDR N/A
- ICUI N/A
- EPS Growth
- FTDR 42.94
- ICUI N/A
- EPS
- FTDR 3.00
- ICUI N/A
- Revenue
- FTDR $1,827,000,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- FTDR $4.72
- ICUI $4.38
- Revenue Next Year
- FTDR $4.35
- ICUI $0.34
- P/E Ratio
- FTDR $19.52
- ICUI N/A
- Revenue Growth
- FTDR 4.16
- ICUI 4.04
- 52 Week Low
- FTDR $29.41
- ICUI $86.80
- 52 Week High
- FTDR $60.42
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- FTDR 61.91
- ICUI 54.19
- Support Level
- FTDR $56.06
- ICUI $151.92
- Resistance Level
- FTDR $57.88
- ICUI $168.50
- Average True Range (ATR)
- FTDR 1.49
- ICUI 5.21
- MACD
- FTDR 0.26
- ICUI 1.20
- Stochastic Oscillator
- FTDR 96.39
- ICUI 73.47
About FTDR Frontdoor Inc.
Frontdoor Inc is a United States-based company that provides home service plans. It owns multiple home service brands including American Home Shield, HSA, OneGuard, and Landmark brands. Through its home service plans, the company helps its customers maintain their homes and protect against costly and unexpected breakdowns of essential home systems and appliances.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.